个性化药物治疗:以蛋白形态学为指导的创新概念
Junwen Su1, Lamei Yang1, Ziran Sun1
1Medical Science and Technology Innovation Center, Shandong Provincial Key Medical and Health Laboratory of Ovarian Cancer Multiomics, & Shandong Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China.
Molecular & cellular proteomics : MCP
|February 14, 2024
概括
个性化医学通过向特定的蛋白质形式而不是仅仅是蛋白质而进步. 这种从蛋白质组学转向蛋白质组学的转变,在量身定制的疗法中提高了药物疗效和患者安全.
科学领域:
- 药理学和药物开发领域
- 生物化学和分子生物学
- 个性化医疗是个性化的医疗.
背景情况:
- 个性化医疗旨在优化药物的疗效和减少不良影响.
- 由于高特异性,蛋白质药物是个性化治疗的关键.
- 目前的蛋白质药物开发忽略了蛋白形变异,影响治疗结果.
研究的目的:
- 建议在个性化蛋白质药物开发中从蛋白质组学转向蛋白质组学.
- 突出针对特定蛋白质的意义,以提高药物的有效性和安全性.
主要方法:
- 审查当前的蛋白质药物开发策略.
- 分析蛋白质组学和质谱学方面的进展.
- 基于蛋白质形式的药物向的概念框架.
主要成果:
- 规范性蛋白质包括多种蛋白质形式,具有不同的药物反应.
- 蛋白形活性的差异可以显著改变药物的疗效和安全性.
- 向蛋白质形式为个性化医学提供了更精确的方法.
结论:
- 对于下一代个性化蛋白质药物来说,过渡到基于蛋白质形式的向是必不可少的.
- 蛋白质形式学将增强对疾病机制和药物发现的理解.
- 这种方法有望改善健康结果和成本效益高,个性化治疗.
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Prodrugs
2.6K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.6K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Drug Biotransformation: Overview
2.4K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.4K
Biopharmaceutics and Pharmacokinetics: Overview
2.0K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.0K
Drug Distribution: Plasma Protein Binding
5.6K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
5.6K


